CU22302A1 - Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales - Google Patents

Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales

Info

Publication number
CU22302A1
CU22302A1 CU90145A CU1990145A CU22302A1 CU 22302 A1 CU22302 A1 CU 22302A1 CU 90145 A CU90145 A CU 90145A CU 1990145 A CU1990145 A CU 1990145A CU 22302 A1 CU22302 A1 CU 22302A1
Authority
CU
Cuba
Prior art keywords
protein
neisseria meningitidis
external membrane
hospedero
approximate
Prior art date
Application number
CU90145A
Other languages
English (en)
Inventor
Blanco Sonia Gonzalez
Santos Beatriz Tamargo
Rodriguez Ricardo Silva
Sosa Manuel Selman Houssein
Nieto Gerardo Enrique Guillen
Martinez Luis Saturnino Herrera
Masso Julio Raul Fernandez
Perez Lidia Ines Novoa
Grillo Juan Morales
Cordova Vivian Morera
Original Assignee
Cigb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cigb filed Critical Cigb
Priority to CU90145A priority Critical patent/CU22302A1/es
Priority to FI914129A priority patent/FI103511B/fi
Priority to IL9940191A priority patent/IL99401A/xx
Priority to CA002050749A priority patent/CA2050749C/en
Priority to AU83683/91A priority patent/AU657487B2/en
Priority to US07/754,918 priority patent/US5286484A/en
Priority to ES91202291T priority patent/ES2103295T3/es
Priority to NO913524A priority patent/NO913524D0/no
Priority to DE69125769T priority patent/DE69125769T2/de
Priority to AT91202291T priority patent/ATE152175T1/de
Priority to AR91320611A priority patent/AR245778A1/es
Priority to EP91202291A priority patent/EP0474313B1/en
Priority to SU5001752A priority patent/RU2132383C1/ru
Priority to JP25587291A priority patent/JP3253327B2/ja
Publication of CU22302A1 publication Critical patent/CU22302A1/es
Priority to GR970401777T priority patent/GR3024127T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01004—Dihydrolipoyl dehydrogenase (1.8.1.4), i.e. lipoamide-dehydrogenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE RELACIONA CON LA RAMA DE LA BIOTECNOLOGIA Y LA INGENIERIA GENETICA, PARTICULARMENTE CON UN PROCEDIMIENTO PARA EL AISLAMIENTO DE UNA SECUENCIA NUCLEOTIDICA QUE CODIFICA UNA PROTEINA DE PESO MOLECULAR APROXIMADO DE 64 000 DALTONS (P64K),LOCALIZADA EN LA MEMBRANA EXTERNA DE NEISSERIA MENINGITIDIS, ASI COMO LOS ACIDOS DESOXIRIBONUCLEICOS (ADN) OBTENIDOS A PARTIR DE ELLA, QUE SON EMPLEADOS PARA LA TRANSFORMACION DE UN MICROORGANISMO HOSPEDERO. EL OBJETIVO TECNICO QUE SE PERSIGUE CON LA SOLUCION PROPUESTA ES LA IDENTIFICACION DE UNA SECUENCIA GENICA QUE CODIFICA PARA UNA PROTEINA ALTAMENTE CONSERVADA Y COMUN PARA LA MAYORIA DE LAS CEPAS PATOGENAS DE NEISSERIA, CON VISTAS A OBTENER DICHA PROTEINA CON UN ALTO GRADO DE PUREZA Y EN CANTIDADES COMERCIALMENTE UTILES POR VIA RECOMBINANTE, DE MANERA QUE LA MISMA PUEDA SER EMPLEADA EN METODOS DE DIAGNOSTICO Y COMO PARTE INTEGRANTE DE UN PREPARADO VACUNAL DE ALTO ESPECTRO INMUNOPROTECTOR. ESTA INVENCION SE BASA EN EL AISLAMIENTO DE UN NUEVO GE N QUE CODIFICA PARA UNA PROTEINA DE PESO MOLECULAR APROXIMADO 64 000 DALTONS (64 KDA) DE LA MEMBRANA EXTERNA DE NEISSERIA MENINGITIDIS B:4:P1.15 Y SU CLONAJE Y EXPRESION EN UN HOSPEDERO PROCARIOTICO (E COLI), POR LO QUE LA MISMA INCLUYE LOS VEHICULOS DE EXPRESION QUE CONTIENEN ESTA SENCUENCIA GENICA, ASI COMO LOS MICROORGANISMOS TRANSFORMADOS CON ESTOS VECTORES CAPACES DE PRODUCIR LA PROTEINA.\!
CU90145A 1990-07-09 1990-09-07 Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales CU22302A1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CU90145A CU22302A1 (es) 1990-09-07 1990-09-07 Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
FI914129A FI103511B (fi) 1990-09-07 1991-09-03 Neisseria meningitidisin ulkokalvon proteiinia koodaava nukleotidisekv enssi
IL9940191A IL99401A (en) 1990-09-07 1991-09-04 Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
CA002050749A CA2050749C (en) 1990-09-07 1991-09-05 Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
AU83683/91A AU657487B2 (en) 1990-09-07 1991-09-05 Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
US07/754,918 US5286484A (en) 1990-07-09 1991-09-05 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations
NO913524A NO913524D0 (no) 1990-09-07 1991-09-06 Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.
ES91202291T ES2103295T3 (es) 1990-09-07 1991-09-06 Secuencia nucleotida codificante para una proteina de la membrana externa de neisseria meningitidis, y su utilizacion en la preparacion de vacunas.
DE69125769T DE69125769T2 (de) 1990-09-07 1991-09-06 Nukleotidsequenz, die für ein Aussenmembran-Protein von Neisseria meningitidis kodiert und Verwendung dieses Proteins zur Herstellung von Impfstoffen
AT91202291T ATE152175T1 (de) 1990-09-07 1991-09-06 Nukleotidsequenz, die für ein aussenmembran- protein von neisseria meningitidis kodiert und verwendung dieses proteins zur herstellung von impfstoffen
AR91320611A AR245778A1 (es) 1990-09-07 1991-09-06 Secuencia de nucleotido que codifica una proteina de membrana exterior de neisseria meningitis y uso de dicha proteina en preparaciones de vacuna
EP91202291A EP0474313B1 (en) 1990-09-07 1991-09-06 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations
SU5001752A RU2132383C1 (ru) 1990-09-07 1991-09-06 ФРАГМЕНТ ДНК, КОДИРУЮЩИЙ БЕЛОК ВНЕШНЕЙ МЕМБРАНЫ NEISSERIA MENINGITIDIS ШТАММА В:4:Р1:15, БЕЛОК ВНЕШНЕЙ МЕМБРАНЫ NEISSERIA MENINGITIDIS, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pМ-6, ШТАММ БАКТЕРИЙ ESCHERICHIA COLI НВМ 64, СПОСОБ ПОЛУЧЕНИЯ БЕЛКА ВНЕШНЕЙ МЕМБРАНЫ NEISSERIA MENINGITIDIS, ВАКЦИННАЯ КОМПОЗИЦИЯ
JP25587291A JP3253327B2 (ja) 1990-09-07 1991-09-07 髄膜炎菌外層膜蛋白質をコードするヌクレオチド配列を有するポリヌクレオチドおよびワクチン組成物
GR970401777T GR3024127T3 (en) 1990-09-07 1997-07-16 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU90145A CU22302A1 (es) 1990-09-07 1990-09-07 Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales

Publications (1)

Publication Number Publication Date
CU22302A1 true CU22302A1 (es) 1995-01-31

Family

ID=5459451

Family Applications (1)

Application Number Title Priority Date Filing Date
CU90145A CU22302A1 (es) 1990-07-09 1990-09-07 Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales

Country Status (15)

Country Link
US (1) US5286484A (es)
EP (1) EP0474313B1 (es)
JP (1) JP3253327B2 (es)
AR (1) AR245778A1 (es)
AT (1) ATE152175T1 (es)
AU (1) AU657487B2 (es)
CA (1) CA2050749C (es)
CU (1) CU22302A1 (es)
DE (1) DE69125769T2 (es)
ES (1) ES2103295T3 (es)
FI (1) FI103511B (es)
GR (1) GR3024127T3 (es)
IL (1) IL99401A (es)
NO (1) NO913524D0 (es)
RU (1) RU2132383C1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
JP4118340B2 (ja) * 1996-09-04 2008-07-16 タカラバイオ株式会社 真菌抗原及びその製造方法
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
AU3968599A (en) * 1998-04-29 1999-11-16 American Cyanamid Company Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis
CN100379757C (zh) * 1998-05-01 2008-04-09 希龙公司 脑膜炎奈瑟球菌抗原和组合物
US6693186B2 (en) * 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
US6756493B1 (en) * 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
JP2004511201A (ja) * 1998-10-09 2004-04-15 カイロン　コーポレイション ナイセリアゲノム配列およびそれらの使用方法
EP1535928B1 (en) * 1998-10-22 2008-07-16 The University of Montana Vaccine compositions comprising Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis
US6610306B2 (en) 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
DE69839740D1 (de) 1998-10-22 2008-08-28 Univ Montana Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis
EP1123403A1 (en) * 1998-10-22 2001-08-16 The University Of Montana OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF
ES2281409T3 (es) * 2000-02-28 2007-10-01 Novartis Vaccines And Diagnostics S.R.L. Expresion heterologa de proteinas de neisseria.
WO2001081422A1 (en) * 2000-04-20 2001-11-01 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Secretory tyrosine phosphatases from mycobacteria
CU23077A1 (es) * 2000-12-06 2005-08-17 Centro Inmunologia Molecular Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
CU23245A1 (es) 2001-07-16 2007-10-17 Inst De Medicina Tropical Pedr CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
MXPA04012496A (es) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Glicoformos del factor vii pegilados.
DE20321889U1 (de) * 2002-08-02 2012-03-12 Glaxosmithkline Biologicals S.A. Impfstoffzusammensetzung
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
DK2353608T3 (da) * 2002-10-11 2020-02-10 Novartis Vaccines And Diagnostics S R L Polypeptid-vacciner til bred beskyttelse mod hypervirulente meningokok-linjer
EP1582217A1 (en) * 2002-11-14 2005-10-05 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Method of obtaining conjugate vaccines and vaccine compositions containing same
CN102212019B (zh) 2003-03-14 2015-05-27 蔚所番有限公司 支化水溶性聚合物及其缀合物
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
WO2004091499A2 (en) 2003-04-09 2004-10-28 Neose Technologies, Inc. Intracellular formation of peptide conjugates
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8361961B2 (en) 2004-01-08 2013-01-29 Biogenerix Ag O-linked glycosylation of peptides
SI1740217T1 (sl) * 2004-04-30 2011-10-28 Novartis Ag Konjugirano meningokokno cepljenje
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
EP1799249A2 (en) 2004-09-10 2007-06-27 Neose Technologies, Inc. Glycopegylated interferon alpha
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
CU23297A1 (es) * 2004-11-16 2008-07-24 Ct De Inmunologa A Molecular Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
CU23578A1 (es) 2005-09-16 2010-09-30 Ct Ingenieria Genetica Biotech Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
CU23630A1 (es) 2006-10-30 2011-02-24 Ct Ingenieria Genetica Biotech Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
CN101796063B (zh) 2007-04-03 2017-03-22 拉蒂奥法姆有限责任公司 使用糖聚乙二醇化g‑csf的治疗方法
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
CN103497247A (zh) 2008-02-27 2014-01-08 诺沃—诺迪斯克有限公司 缀合的因子viii分子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン

Also Published As

Publication number Publication date
DE69125769D1 (de) 1997-05-28
IL99401A0 (en) 1992-08-18
IL99401A (en) 2003-12-10
ATE152175T1 (de) 1997-05-15
FI103511B1 (fi) 1999-07-15
JP3253327B2 (ja) 2002-02-04
NO913524D0 (no) 1991-09-06
EP0474313B1 (en) 1997-04-23
JPH06169779A (ja) 1994-06-21
AR245778A1 (es) 1994-02-28
FI103511B (fi) 1999-07-15
ES2103295T3 (es) 1997-09-16
DE69125769T2 (de) 1997-11-27
FI914129A0 (fi) 1991-09-03
RU2132383C1 (ru) 1999-06-27
EP0474313A2 (en) 1992-03-11
AU8368391A (en) 1992-03-12
CA2050749C (en) 2002-07-02
US5286484A (en) 1994-02-15
GR3024127T3 (en) 1997-10-31
FI914129A7 (fi) 1992-03-08
CA2050749A1 (en) 1992-03-08
EP0474313A3 (en) 1993-02-24
AU657487B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
CU22302A1 (es) Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
CN101432296B (zh) 聚乙二醇化的突变的肉毒梭菌毒素
US8629097B2 (en) Macromolecule transduction domains and methods for identification and uses thereof
CU22559A1 (es) Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
BR0015137A (pt) Peptìdeos antigênicos de neisseria
BR0208944A (pt) quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
DE69327645D1 (de) Dna-sequenzen kodierend für neuartige wachstums-/differentierungsfaktoren
PE20241621A1 (es) Composiciones de polinucleotidos y sus usos
PE20020572A1 (es) Preparaciones para potenciar la inmunogenicidad de antigenos poco inmunogenicos
US20240181029A1 (en) Slam polynucleotides and polypeptides and uses thereof
ATE235916T1 (de) Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern
ES2094907T3 (es) Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano.
BRPI0519923A8 (pt) polipeptídeo, seqüência de dna, vetor de dna, anticorpo, bactéria, método para produzir lps parcialmente 3-0-desacilado, composição, usos da bactéria, e de lps de bordetella isolado compreendendo lps pelo menos parcialmente 3-0-desacilado, vacina, e, método in vitro para a desacilação de lps gram-negativo ou de composições compreendendo lps gram-negativo, e, para induzir uma resposta imune contra bordetella.
PT914437E (pt) Identificacao e clonagem de um antigenio micobacteriano correspondente a uma hemaglutinina de ligacao a heparina
DK128490D0 (da) Renset gensekvens, som koder for protein ia, ib eller begge fra neisseria gonorrhoeae, rekombinantvektorer og organismer indeholdende sekvenser, dens fremstilling og anvendelse, neisseria-stamme og dennes paavisning
AR053372A1 (es) Proteinas inmunologicas de lawsonia intracellularis
KR102454254B1 (ko) 다당류에 단백질이 포합된 폴리머, 그 제조 방법, 이를 포함하는 효소 안정화 조성물 및 이를 이용한 표적 핵산 분자 검출 방법
BR0002602A (pt) Vacina viva atenuada, uso de uma bactéria viva atenuada, e, processo para a preparação de uma vacina
KR101905460B1 (ko) 네이세리아 고노르호에아 유래 탄산무수화효소를 이용한 탄산무수화 활성이 증가된 형질전환체
Griffiths et al. Antigenic relationships of transferrin-binding proteins from Neisseria meningitidis, N. gonorrhoeae and Haemophilus influenzae: Cross-reactivity of antibodies to NH2-terminal peptides
Chertkova et al. An artificial protein with the biological activity of the differentiation factor for the HL-60 cell line of human promyelocyte leukemia
AR041243A1 (es) Vacuna para ostertagia
AR133808A1 (es) Composiciones inmunogénicas contra la influenza
MX2022002602A (es) Inmunogenos recombinantes para la produccion de anticuerpos contra el veneno de alacranes del genero tityus y centruroides.
CY1117066T1 (el) Αντιγονικα πεπτιδια neisseria